We invite all our readers to take part in our Hybridan Newsletters
and Equity Research Survey by clicking on the link: here
* A corporate client of Hybridan LLP.
** Potential means Intention to Float (ITF) or similar announcement has been made.
***Arranged by type of listing and date of announcement.
****Alphabetically arranged and priced on Share Price and Market Capitalisation during the time of writing on the day of Publication.
Admissions:
None
Delistings:
None
What’s baking in the oven?
Potential IPOs:***
3 June: Reveille Resources has announced its intention to IPO onto AQSE. The strategy is focused on identifying and advancing uranium exploration opportunities in assets that have benefited from significant historical expenditure and technical work, but which may not have achieved full value realisation due to geopolitical, technological, financial, or historical factors. Reveille’s initial focus is on two historical uranium deposits in Lombardy, northern Italy. Deal details TBC and expected Admission date is 17 June 2026.
21 May: Coastal Africa Group, a newly formed incorporated Company focused on acquiring and investing in the oil and gas sector, energy infrastructure, energy services and energy assets across West Africa, has announced its intention to IPO onto AIM. The expected Admission date is anticipated early June 2026.
17 March: Vista Parcs Group has announced its intention to IPO onto AIM. The newly incorporated entity is proposing to acquire a portfolio of 13 UK-based holiday and residential parks currently owned by Barney Group 2 Ltd (BG2) and operated by Baslow Parks Ltd. Deal details TBC and expected Admission date anticipated late June 2026.
Reverse Transactions:***
19th December 2025: Talon Resources (TAR.L), previously Medcaw Investments, the Company focused on identifying and acquiring prospective mining projects in the precious metals sector, with a primary focus on gold and other high-value commodities announced that it has entered into binding heads of terms (which includes an exclusivity agreement until 31 October 2026) with Ulvestone Ltd in respect of the proposed acquisition by the Company of 90% of the legal and beneficial interest in certain mineral exploration licences located in Ontario, Canada. The aggregate consideration payable by Medcaw is £4.17m, to be satisfied £70k in cash on execution of the definitive share purchase agreement, £100k in cash on AIM Admission, and £4m satisfied through the issue of new ordinary shares in Medcaw at a price of 1.5p per share, to be issued on AIM Admission. The indicative timetable in relation to the Cancellation and proposed re-admission to trading on AIM has been revised and is now expected to take effect on 23 June.
Market Movers:***
1st June: Mendell Helium (AQSE: MDH), the helium production company with operations in Kansas, announced its intention to move to AIM during the week beginning 15 June. No new Ordinary Shares are being issued or allotted in conjunction with Admission to trading on AIM with an anticipated market capitalisation on Admission of approximately £15m.
Banquet Buffet****
London Stock Exchange: Main Market and AIM
Active Energy Group 0.11p £6.97m (AEG.L)
The digital infrastructure and energy platform focused on the Gulf Cooperation Council (GCC) region is engaging with senior officials from the Bahrain Economic Development Board at a GCC digital infrastructure event taking place in London. It is to discuss the continued growth of digital infrastructure across the Gulf region and explore potential opportunities within the Kingdom of Bahrain. The Company has successfully established its initial operational footprint within the United Arab Emirates and continues to evaluate opportunities to expand.
Cindrigo Holdings Ltd 5.50p £16.26m (CINH.L)
The sustainable energy developer with a portfolio of projects that support Europe's transition to sustainable energy future reports that banking arrangements required to facilitate a strategic investment and the Fuelwood joint venture have been finalised and the Company can expect to receive the investment funds shortly.There is an active development strategy with several energy projects and licenses under evaluation.
Huddled Group 0.70p £3.15m (HUD.L)
The circular economy e-commerce business reports results for the FY 31 December 2025 and updates on Trading. Revenue increased 44% to £18.65m and the Company reported a gross profit margin of 3.9% compared to 0.27% in the prior year. The EBITDA loss narrowed to £2.65m from £2.94m in the prior year, which was achieved with disciplined decision making to prioritise quality of earnings over revenue. The YE net debt was £0.468m. Q1 2026 revenue was £4.2m, compared to £4.4m in Q1 2025, continuing the strategic decision to moderate volume while structural issues were addressed to remove uneconomic low-value items. The CEO states there is a great value proposition, next-day delivery, genuine customer loyalty, and the margins to justify scaling so the future should be exciting.
ELECO 132.5p £109.46m (ELCO.L)
The specialist software provider for the built environment reports on trading at the AGM. The business performance has progressed over the first four months of the FY2026 as the Company continues to deliver on its growth strategy. Their software solutions are used throughout the building lifecycle from early planning and design stages to construction, interior fit out, asset management and facilities management to support project management by clients internationally and the Company is well positioned for growth.
Landore Resources Limited 1.85p £6.96m ( LND.L)
The 100% owner of the highly prospective BAM Gold Project, Northwestern Ontario, Canada, reports the FY to 31 December 2025 in which meaningful progress has been made in strengthening its strategic direction, advancing the BAM Gold Project and positioning the Group for sustained value creation. The Loss Before Tax increased to £2.85m from £2.55m in the prior year, with net cash of £0.91m compared to £2.1m in the prior year as financing was secured via the successful completion of an equity placing and exercise of warrants during the year, raising a total of £1.71m. The CEO states the foundations are laid for a transformative period.
Ramsdens Holdings 487.5p £148.03m (RFX.L)
The diversified financial services provider and retailer updates on trading for the Interim Results for the six months ended 31 March 2026. The Company has continued to perform well across its core income streams of pawnbroking, jewellery retail and foreign currency exchange services. There has been further benefits from the sustained, very high gold price compared to historical levels. The Board, however, is conscious that although the current geopolitical and economic climate has made the gold price volatile, this uncertainty may also negatively impact on international travel and consequently the foreign currency sales. Despite this cautionary stance, the Board now expects its profit before tax for FY26 to be at least £28.5m and, if the favourable gold price continues and summer currency volumes are in line with last year, potentially up to £31.5m.
Sutton Harbour Group 3.75p £5.36m (SUH.L)
The Company specialising in marine operations, waterfront regeneration and destination creation in Plymouth and Southwest England reports the independent annual property asset valuation has now been completed with an estimated portfolio value, as at 31 March 2026, of £45.72m which is a 5.7% decrease in value. The valuations exclude the former airport site. On 1 June 2026, the sale of North Quay House was completed with a sale price equal to the estimated valuation of £1.25m as at 31 March 2026. This disposal will permit further reduction of bank debt. The Company continues to progress interest in the disposal of other selected assets to further reduce bank debt and to provide working capital.
Tan Delta Systems 31.0p £23.8m (TAND.L)
The intelligent real time sensor-based monitoring and maintenance systems for commercial and industrial equipment reports finals for the FY to 31 December 2025. Revenue is unchanged at £1.22m, with gross margins of 60% compared to 62% leading to a loss before tax which increased to £1.55m against a loss before tax in the prior period of £1.14m. The net cash was lower at £1.49m compared to £3.1m in the prior period. The commercial opportunity pipeline increased to over £75m from £35m in the prior period with multiple paid-for customer evaluations progressing towards potential fleet-wide rollouts. The challenge has been ensuring there are sufficient resources to support the growing number of evaluations and prepare for anticipated future rollouts. The timing of customer deployment decisions remains difficult to predict, but several ongoing evaluations are expected to progress towards commercial rollout decisions in 2026.
Venture Life Group 63.0p £68.83m (VLG.L)
The proactive provider of longevity, health innovation and global commercialisation within the consumer healthcare sector acquires two brands FemiClear and CUROXEN, from OrganiCare Nature's Sciences, for a total consideration of up to $28.0m. The Brands have built a strong presence in the US, with distribution across major retailers, pharmacies and online channels, including Walmart, Walgreens, CVS and Target, and have delivered a net revenue CAGR of 22.5% over the last two financial years, with FemiClear representing approximately 98% of the financial performance. The Board considers the acquisition to be perfectly aligned with the Group's strategy and significantly strengthens Venture Life's position within Women's Intimate Health. Meaningful synergies are expected at both a revenue and operating level so will be margin enhancing to the Group.
Vianet Group 67.0p £18.9m (VNET.L)
The international provider of actionable data, business insights and payment solutions reports the renewal of a contract with Admiral Taverns for a further five-years. The renewed agreement covers almost 1,100 sites across the Admiral Taverns estate to continue providing Smart Zones Beverage Metrics draught beer monitoring and data analytics solutions. The agreement strengthens the Group's highly recurring revenue model, with recurring revenues of around 88% of Group revenues. These long-term partnerships are central to the growth strategy as the earnings visibility enables the continued investing in innovation, advanced data analytics and AI-driven insights to further improve clients operational performance and profitability.
Status of this Note and Disclaimer
This document has been provided as a general market commentary and is issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as investment advice; a recommendation; an offer to sell; nor solicitation of any offer to buy any security or other financial instrument. Nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. The information has been provided without taking into account the investment objective, financial situation or needs of any particular person. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
As market commentary, this document is not investment research or a research recommendation for regulatory purposes as it does not constitute substantive research or analysis. It is not subject to any prohibition on dealing ahead of the dissemination of investment research although Hybridan LLP maintains related internal systems and controls in connection with such dealing.
This document should not be relied upon as being an independent or impartial view of the subject matter. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result, both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
This document is not intended to be an invitation or inducement to engage in investment activity. In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are categorised by Hybridan LLP as either a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority's Conduct of Business Sourcebook) (all such persons referred to in (i) and (ii) together being referred to as "relevant persons"). This document must not be acted on or relied up on by persons who are not relevant persons. For the avoidance of doubt, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority's Conduct of Business Sourcebook.
The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. The information may contain projections or other forward-looking statements regarding future events, targets or expectations. There is no assurance that such events or expectations will be achieved, and actual results may be significantly different from that shown here. The information is based on current market conditions, which will fluctuate and may be superseded by subsequent market events or for other reasons. Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein.
References to specific securities, asset classes and financial markets are for illustrative purposes only. Past performance is no guarantee of future results. Information and opinions presented have been obtained or derived from sources which Hybridan LLP reasonably believed to be reliable however no representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.
To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any losses arising in any way from use of all or any part of the information in this document including, for the avoidance of doubt, direct or indirect or consequential loss or damage (including lost profits).
Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom or any other jurisdiction in any part of the world.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication.
In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
Unless otherwise stated, Hybridan LLP owns the intellectual property rights and any other rights in this document. This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.
